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ABSTRACT 
The human intestine hosts a diverse community of bacteria known as the intestinal 
microbiota.  The intestinal microbiota have a symbiotic relationship with the host 
organism.  Current research does not clearly define the effect these commensal 
microorganisms have on the overall maintenance of gastrointestinal health, including 
protection from the invasion and pathogenesis of foreign bacteria known as pathogens.  
EHEC O157:H7 causes severe sickness and can be life-threatening, but is difficult to 
study in vivo.  One challenge is that EHEC does not colonize the preferred animal model 
for human GI studies: the murine intestine.  However, the murine pathogen Citrobacter 
rodentium has been shown to colonize the mouse intestine and is used in current research 
as a model for EHEC colonization and infection.  However, no one knows how the 
intestinal microbiota respond during the colonization C. rodentium and is addressed in 
this thesis.  The colonization of a streptomycin-resistant strain of C. rodentium was 
observed over a 15-day period and quantified in both conventional and streptomycin-
treated mouse models using genus-specific primers and quantitative PCR.  The day 7 
results indicate that there is a significant increase of Bacteroidales in the uncolonized, 
streptomycin-treated model, which is consistent with previous studies.   The 
characterization of the intestinal microbiota has yet to be fully described for the 
colonization of C. rodentium in the mouse intestine as data analysis for this study 
continues.  The anticipated outcomes may lead to the prevention and clinical care of 
EHEC on a global scale. 
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The Gut Reaction: How the Intestinal Microbiota Respond to Colonization by 
Citrobacter rodentium 
INTRODUCTION 
1. Gastrointestinal tract and its microbes 
Gastrointestinal (GI) health is becoming increasingly popular in science and 
health-related fields, especially concerning disease prevention and overall human health.    
Within the GI tract exists a dynamic microcommunity that contains a diverse number of 
species each with a unique role in maintaining the health of the host (1).  This 
microcommunity is known as the intestinal microbiota.  At least 800 different bacterial 
species comprise the intestinal microbiota with 1013 to 1014 total bacteria present at a 
given time (2-4).  The mutually beneficial relationship between the intestinal microbiota 
and the host is not completely understood, although the interactions that exist microbe-to-
microbe as well as microbe-to-host may contribute to preventing disease and promoting 
health (5).  Effectively relating GI health to clinical practice is impossible without 
understanding the basic nature, i.e. relationships among different microbes, genetic and 
metabolic attributes, fluctuations occurring in the onset of infection, etc., of the microbial 
community occupying the GI tract.    
2. Models for study 
A proper enteric model is needed to accurately study the dynamic interactions of 
the intestinal microbiota.  An in vivo model has proven superior to other modes of study 
because it not only accounts for the physiological conditions of a real-life situation but 
also for the anaerobic nature of the commensal gut bacteria (6).  Rodents are used to 
model the human GI tract because they share similar anatomical structures: both species 
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have a duodenum, jejunum, large and small intestine, and cecum, although the cecum of 
rodents is more pronounced than that of humans (7, 8).  Rodents are preferred over other 
mammals because their diet and environment are easy to control and monitor.  In 
addition, many research studies have obtained physiologically consistent results to those 
observed in humans (9). 
In current research, there exist three murine models to study the interactions 
between a host and a given bacterium: gnotobiotic, conventional, and streptomycin-
treated.  The efficacy and practical application to in situ conditions must be considered 
when choosing a model.  Gnotobiotic (germ-free) mice have no commensal microbes to 
impede the introduction of an invading microbe into the system.  In practical use, this 
model is used to introduce specific elements back into a sterile system.  However, 
introducing a bacterial cocktail back into the GI tract post-infection does not account for 
the complex interaction between a commensal microbial community and an invading 
bacterium; elements of real-world situations are lost entirely.  Thus, the gnotobiotic 
mouse model may not be the model of choice for applications to clinical research in 
relation to the other two models.   
The conventional mouse model maintains the commensal microbial community 
the gnotobiotic mice lacks.  The presence of the normal gut microbiota makes the 
conventional model ideal for studying pathogenesis; this model represents the conditions 
that an invading microbe would face in situ.  However, its use for other types of studies 
(i.e. colonization studies) is limited for the same reason; the normal gut microbiota makes 
the survival of a foreign microbe in the system difficult.  Hence, the need exists for an in 
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vivo model that allows for the introduction of an invading microbe into a system while 
maintaining the physiological conditions of an in situ model.   
Studies have shown that pre-treating mice with antibiotics (i.e. streptomycin) 
allows for enteric pathogens to grow competitively within the mouse intestine, although 
the mechanism by which this occurs is poorly understood (10, 11).  It has been 
hypothesized that streptomycin treatment decreases the intestinal mucosal layer of 
commensal facultative anaerobes, freeing up nutritional niches, and vacating space (12-
14).  In addition, streptomycin does not alter the mucosal layer of the GI tract as severely 
as other antibiotics, which reduce the mucosal layer and in effect initiate a pathogenic 
state (15).  Many studies report only pre-treating mice with streptomycin and then 
discontinuing the treatment for the rest of the study.  These mice were asymptomatic in 
the beginning of the study, but showed signs of pathogenesis at the end of the study.  
Therefore, a given pathogen cannot be properly studied in the pre-pathogenic state with 
pre-treatment alone.   
Contrary to pre-treatment with streptomycin, continuous streptomycin treatment 
maintains a pre-pathogenic state.  Recent studies suggest that continuous streptomycin 
treatment interferes with microbe-host interactions by increasing nitrate availability via a 
slight inflammatory response, which may affect the persistence of the invading microbe 
in the intestine (16, 17).  Thus, the continuous streptomycin-treated mouse model is the 
best model to describe how a foreign microbe maintains growth and survives within the 
intestine without inducing pathogenesis (14, 18).   
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3. Commensal bacteria within the intestine 
In the intestine there exist a number of microhabitats where both commensal and 
pathogenic bacteria reside.  Commensal, non-pathogenic bacteria typically reside in two 
places: either in the mucus layer covering the intestinal epithelial cells or in the luminal 
contents.  The intestinal epithelial cells secrete a mucus layer that covers the entire GI 
tract.  This mucus layer assumes an important role in maintaining and protecting both the 
microbiota as well as the host cells from invading pathogens.  In addition to acting as a  
protective covering over the intestinal epithelia,  the mucus layer separates the cell wall 
of the intestine from the lumen, and serves as a source of nutrients for commensal strains 
of bacteria (1, 6, 19).  In general, the normal microbiota are found in the mucus layer 
because they cannot maintain a growth rate equal to or greater than the turnover rate of 
the intestinal epithelial cells (3).  Sloughing and degradation of the mucus layer results in 
the presence of commensal bacteria in the luminal contents, offering another form of 
protection against invading microbes (19).  Protection from invading microbes is the 
basis of disease prevention, with the intestinal microbiota being the most fundamental 
source of protection in the mammalian host.  
4. Pathogenic bacteria within the intestine  
In contrast to commensal bacteria, pathogenic bacteria are generally found in 
close proximity to the intestinal epithelia; however, they do not necessarily grow faster 
than either their commensal counterparts or the turnover rate of the intestinal epithelia.  
The pathogenic nature of bacteria is a result of their ability to produce an array of 
virulence factors otherwise lacking in commensal strains (20).  Through the use of 
virulence factors, pathogenic bacteria compromise the integrity of the intestinal epithelia; 
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the physical separation of the luminal contents from the rest of the body is no longer 
functional.  Thus, disease is promoted throughout the host.  The pathogenicity of a 
foreign microbe to the host intestine is not only affected by its location within the 
intestine, virulence factors, and genetic differences from commensal bacteria, but it is 
also a function of the ability of a given pathogen to grow, survive, and  maintain stable 
existence in a particular niche of the intestine (3, 6).  
5. Colonization within the intestine  
Colonization may be described as the ability of a bacterium to compete for 
nutrients and maintain a growth rate equal to or greater than the turnover rate of the 
intestinal epithelia (8).  The degree of pathogenicity of a given bacterium not only 
depends on the virulence and successful competition for space, nutrients, and host 
receptors of the bacterium but it also depends on its colonization success.  Colonization is 
the first step to pathogenesis, making the need for a suitable model of the colonization 
period even more critical, especially as it relates to disease prevention (1, 21, 22).  
6. Microbial composition in colonic mucus  
Facultative anaerobes, including Escherichia coli, make up about 0.1% of the 
intestinal microbiota (23).  Escherichia coli is the most abundant facultative anaerobe 
found in the mucosal layer of the intestine and is the most studied microorganism (6, 21).  
Although it only makes up a small percentage of the total microbiota, E. coli is found in 
nearly every mammal in similar abundances.  The potential protective role of commensal 
E. coli against pathogenic strains of E. coli has also been implicated (18).   
The dominant enteric species inhabiting the large intestine include Bacteroides 
spp., Bifidobacterium spp., Clostridium spp., Lactobacillus spp., and Enterococcus spp., 
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but their roles in the functional stability of the complex microbial community of the GI 
tract is not well known (19).  The populations of obligate anaerobes Bacteroides, 
Clostridia and Bifidobacteria are not altered significantly when treated with 
streptomycin, but the populations of Lactobacillus and facultative anaerobes typically 
decreased under the same conditions (10).  Bacteroides and Clostridium are the most 
abundant obligate anaerobes, with Bacteroides having an eclectic composition of 
different species (4).   
7. Colonization resistance 
Colonization resistance describes the challenge a microbe faces to colonize a 
given system.  The GI tract asserts a level of colonization resistance against foreign 
bacteria via the function and presence of host commensal microbes.  In the conventional 
mouse model, commensal bacteria elicit host immunological responses via their 
interaction with the intestinal epithelia to ward off infection by a foreign microbe, such as 
pathogenic E. coli (24).  In contrast, the streptomycin-treated mouse model eliminates 
many factors impeding the colonization success of a given enteric pathogen.  Factors 
contributing to colonization resistance include competition for mucosal carbon sources 
among commensal and pathogenic strains, competition for space, and respiration needs.  
Some pathogens, such as Enteropathogenic E. coli, may overcome colonization resistance 
via the utilization of multiple carbon sources and the co-metabolism of several carbon 
sources to maintain colonization (25).  Overcoming colonization resistance is necessary 
for pathogenesis to ensue. 
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8. Pathogenic Escherichia coli 
Enteropathogenic Escherichia coli (EPEC) and Enterohemorrhagic Escherichia 
coli (EHEC) are Gram-negative enteric pathogens.  EPEC colonizes the small intestine 
while EHEC colonizes the large intestine.  In humans,  EPEC and EHEC share many 
virulent factors and can cause colitis with instances of bloody diarrhea (26).  EHEC 
O157:H7 causes life-threatening hemolytic uremic syndrome in humans, but exhibits 
commensal-like behavior in cattle and streptomycin-treated mice (27).  Also, EHEC 
colonization is poorly understood partly due to its inability to colonize the conventional 
mouse intestine (28).  Its commensal-like behavior and its poor colonization present a 
unique challenge for studying the colonization of EHEC O157:H7 in an animal model, 
and, therefore, requires another means by which it can be studied in the mouse intestine. 
9. Citrobacter rodentium as a model for EHEC  
A member of Enterobacteriaceae, the enteric murine pathogen Citrobacter 
rodentium is genetically similar to EHEC and EPEC, but does not induce pathogenesis in 
humans (9, 29).  However, it is considered highly infectious to mice.  C. rodentium 
targets the cecum and colon during infection and causes colonic hyperplasia (9).  Not 
only do genetic similarities exist between C. rodentium and EHEC and EPEC, but also 
similarities in virulence factors (i.e. attachment mechanisms) have been observed among 
the pathogenic strains (9, 30-32).   
In mice infected with C. rodentium, the colonic response is similar to the response 
induced in humans by EHEC infection (9, 30, 33); in short, C. rodentium is to mice what 
pathogenic E. coli is to humans.  However, the known virulence mechanisms of C. 
rodentium in the murine intestine are not well-defined (32, 34).  Because of its genetic 
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and virulent similarities to EHEC, C. rodentium in the murine intestine serves as a 
suitable model for EHEC in the human intestine.  There is a gap in current research 
regarding the microbial response to enteric colonization of EHEC and the potential role 
of the intestinal microbiota in preventing the disease caused by the pathogen.  I 
hypothesize that Bacteriodales spp. and Clostridium spp. will have significantly altered 
population abundances when streptomycin-treated mice are colonized with C. rodentium.  
The results from this thesis will be the first time the bacterial community is quantified 
and examined with the colonization and infection of C. rodentium in the streptomycin-
treated mouse model.  Inferences may then be made concerning the interaction between 
the human intestinal microbiota and pathogenic Escherichia coli.  The anticipated 
outcomes of this study may have applications in regard to future preventative measures 
made in response to the global health threat and disease caused by EHEC. 
 
MATERIALS AND METHODS 
1. Conventional mouse model 
The conventional mouse model was the model for studying the pathogenesis 
induced by infection with C. rodentium.  Three male, 6-week old CD-1 mice (Charles 
River) were starved of food and water for 18-24 hours before being orally fed a 20% 
sucrose suspension containing 105 CFU of C. rodentium strain DBS100 Strr 
(streptomycin-resistant strain) (ATCC 51459).  After the bacterial suspension was 
ingested, food and water were returned ad libitum.  Fecal samples were collected and 
bacterial load was quantified 5 hours, 24 hours, and every other day post infection for 15 
days.  The mice were then euthanized by CO2 gas asphyxiation and cervical dislocation 
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before the ceca and colons were harvested.  Three male, 6-week old CD-1 mice that were 
not given the bacterial suspension served as controls. 
2. Streptomycin-treated mouse model 
The streptomycin-treated mouse was the model for studying the colonization of 
the mouse large intestine by C. rodentium.  Three male, 6-week old CD-1 mice (Charles 
River) were given drinking water containing streptomycin-sulfate (5 g/L) to decrease the 
resident facultative anaerobic microbiota.  Mice were then starved of food and water for 
18-24 hours before being orally fed a 20% sucrose suspension containing 105 CFU of C. 
rodentium DBS100 Strr.  After the bacterial suspension was ingested, food and 
streptomycin water were returned ad libitum.  Fecal samples were collected, bacterial 
load was quantified, and mice were euthanized as was done with the conventional mice.  
Three male, 6-week old CD-1 mice that were treated with streptomycin and not given the 
bacterial suspension served as controls. 
3. CFU determination 
To determine the number of colony forming units (CFU), the fecal samples were 
homogenized and serially diluted in 1 mL of 1% tryptone broth for every 0.1 g feces, and 
plated on MacConkey agar containing streptomycin only (100 µg/ml).  The fecal plates 
were incubated overnight at 37°C, and bacterial colonies were counted the following day. 
Colonies that were round with a red center and white rim were identified as C. rodentium.  
In reality, fecal samples contain a smaller amount of the population of interest when 
compared to cecal samples; however, collecting fecal samples is standard procedure for 
bacterial quantification and is less intrusive compared to cecal sampling (35). The log10 
mean number of CFU per gram of feces for either strain in the mice was calculated for 
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each time point.  The statistical significance for each CFU/g feces result was determined 
using a Student’s t test (two-tailed with unequal variance).  
4. Fecal genomic DNA isolation 
Genomic DNA was extracted from the collected fecal samples from days 1, 3, 7, 
and 15 of the colonization period using the QIAamp DNA Stool Mini Kit (Catalog 
#51054) (Qiagen) according to the manufacturer’s instructions. Genomic DNA 
concentration was determined at a wavelength of 260 nm using a NanoDrop 2000 
Spectrophotometer (Thermo Scientific). 
5. Relative quantitative PCR of genomic DNA 
Relative quantitative PCR (qPCR) was employed using SsoFast EvaGreen 
SuperMix (Bio-Rad #172-5201) and the primers listed in Table 1 for the day 7 samples 
for both control and experimental groups.  qPCR was performed with cycles consisting of 
95°C for 15 min and 40 cycles of 94°C for 15 s, 60°C for 30s, and 72°C for 30 s (15).  
qPCR was performed first on pure cultures to test the accuracy of the primers. The start 
of amplification was recorded at a particular cycle number (Cq) for each genus, and the 
Cq value for the Eubacteria (total bacteria) was used a standard against the specific 
bacterial abundances.  The change in Cqs (∆Cq) was determined and was then used to 
calculate the relative population abundance by raising 2 to the -∆Cq.  
 
RESULTS 
1. Colonization Results 
The genotypic and phenotypic profiles of the gastrointestinal microbiota may be 
altered by changes occurring in the intestinal microenvironment.  The introduction and  
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Table 1. Quantitative PCR Primers 
Target 16S rRNA Primer Sequence Reference 
Eubacteria (total 
bacteria) 
UniF340 
UniR514 
ACTCCTACGGGAGGCAGCAGT 
ATTACCGCGGCTGCTGGC 
 
(15) 
Bacteroidales     BactF285 
    UniR338 
 
GGTTCTGAGAGGAAGGTCCC 
GCTGCCTCCCGTAGGAGT 
 
(15) 
Clostridium 
coccoides 
UniF338 
CocR491 
 
ACTCCTACGGGAGGCAGC 
GCTTCTTAGTCAGGTACCGTCAT 
 
(15) 
Lactobacillus LabF362 
LabR677 
AGCAGTAGGGAATCTTCCA  
CACCGCTACACATGGAG 
(15) 
Enterobacteriaceae 
 
Coli F 
Coli R 
GTGCCAGCMGCCGCGGTAA 
GCCATAACGTTGAAAGATGG 
(36) 
Bifidobacterium Bif164F 
Bif662R 
GGGTGGTAATGCCGGATG 
CCACCGTTACACCGGGAA 
(15) 
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colonization of C. rodentium strain DBS100 may be considered an important change in 
the intestinal microcommunity; this change as well as other physiological conditions may 
affect its colonization in vivo.  Therefore, the pathogenesis and colonization of 
Citrobacter rodentium strain DBS100 Strr were observed by using both conventional and 
streptomycin-treated mouse models over a 15-day period.  The log CFU/g feces during 
the C. rodentium DBS100 Strr colonization assay of both experimental groups were 
determined (Figure 1).  The degree to which each respective strain colonized the intestine 
was assessed via the number of CFUs that persisted in the feces. 
The first day shows no statistical difference in log CFU/g feces between the 
conventional and streptomycin-treated models.  However, a significant divergence 
between the two models is observed beginning at day 7 and continuing to day 15 of the 
experiment (Figure 1).  Quantifying the population abundance of the most prominent 
bacteria in the intestinal microbiota will increase the understanding of the colonization 
results and the role the bacterial community has in the infection with C. rodentium strain 
DBS100 Strr.  
2. Relative qPCR results for day 7  
To describe the gastrointestinal community dynamics associated with day 7 of the 
colonization period, relative qPCR was used with genera-specific primers of the bacterial 
16S rRNA gene (Table 1).  The respective bacterial population abundances were 
normalized to the total bacteria 16S rRNA gene copies in each sample.   The 
Bacteroidales population was significantly higher in the streptomycin-treated mouse 
control compared to the conventional control, having over a three-fold increase in 
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Figure 1. The colonization of C. rodentium strain DBS100 Strr in conventional and 
streptomycin-treated mice. The log CFU/g of feces for both groups are nearly 
indistinguishable for day 1 and then begin to display a significant difference on day 7, 
with  the conventional mice having significantly higher colonization than the 
streptomycin-treated mice by the end of the colonization period.  
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the streptomycin-treated intestine.   There was a five-fold increase in Bacteroidales 
population abundance in the colonized, conventional model versus its control, and nearly 
a two-fold increase in the colonized, streptomycin-treated intestine versus its control 
(Figure 2).  However, neither one of these results are considered significant differences.  
 The Clostridia population had a two-fold decrease in the streptomycin-treated intestine 
control versus the conventional control (Figure 3). There was not a significant increase in 
population abundance in the colonized, conventional model, and less than a two-fold 
increase in the streptomycin-treated mouse model.  Neither the conventional nor the 
streptomycin-treated mouse intestine had significant Clostridia differences with the 
colonization of C. rodentium when compared to their respective controls.  Also, 
Clostridia population abundances in the presence of C. rodentium did not alter 
significantly with the antibiotic treatment (Figure 3).   
The Lactobacilli population abundance did not change with antibiotic treatment 
alone (i.e. the controls had almost the same abundance).  The conventional group 
colonized with C. rodentium had a significant increase of over seven-fold compared to its 
control, and a four-fold increase compared to the streptomycin-treated group colonized 
with C. rodentium (Figure 4).  The Bifidobacteria population did not display a 
significance difference between the control groups or between the streptomycin-treated 
control and the colonized streptomycin-treated mouse intestine (Figure 5).  The 
Enterobacteriaceae population abundances did not significantly differ between any of the 
experimental groups, including the controls (Figure 6).  Figure 7 displays the collective 
relative abundances of each of the chosen genera. 
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Figure 2. The bacterial abundance percentage for Bacteroidales. Quantitative PCR of 
Bacteroidales populations using group-specific primers on DNA extracted from fecal 
samples. The abundance of Bacteroidales was normalized to the total bacterial 16S rRNA 
gene copies in each sample. Results had n = 3 mice per group. Student’s t-test reveals a 
significant difference between control groups (P<0.05). Error bars represent standard 
errors of the mean (SEM).  
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Figure 3. Bacterial abundance percentage of Clostridium. Quantitative PCR of 
Clostridia populations using group-specific primers on DNA extracted from fecal 
samples. The abundance of Clostridia was normalized to the total bacterial 16S rRNA 
gene copies in each sample. Results had n = 3 mice per group. Student’s t-test reveals no 
significant difference between control groups or between the colonized/streptomycin 
model (P>0.05).  Error bars represent SEM. 
 
 
 
 
 
 
 
 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
Conv Strp CR CR+Strp
C
lo
st
ri
d
ia
 A
b
u
n
d
a
n
ce
 
(%
 o
f 
to
ta
l 
1
6
S
 r
R
N
A
 g
e
n
e
 c
o
p
ie
s)
THE GUT REACTION  20 
 
 
Figure 4. The bacterial population percentage of Lactobacilli. Quantitative PCR of 
Lactobacilli populations using group-specific primers on DNA extracted from fecal 
samples. The abundance of Lactobacilli was normalized to the total bacterial 16S rRNA 
gene copies in each sample. Results had n = 3 mice per group. Student’s t-test reveals no 
significant difference between control groups or between the experimental groups versus 
their respective controls (P>0.05).  Error bars represent SEM. 
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Figure 5. The bacterial population percentage of Bifidobacterium. Quantitative PCR 
of Bifidobacterium populations using group-specific primers on DNA extracted from 
fecal samples. The abundance of Bifidobacteria was normalized to the total bacterial 16S 
rRNA gene copies in each sample. Results had n = 3 mice per group. Student’s t-test 
reveals no significant difference between control groups or between the experimental 
groups versus their respective controls (P>0.05).  Error bars represent SEM. 
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Figure 6. The bacterial population percentage of Enterobacteriaceae. Quantitative 
PCR of Enterobacteriaceae populations using group-specific primers on DNA extracted 
from fecal samples. The abundance of target groups was normalized to the total bacterial 
16S rRNA gene copies in each sample. Results had n = 3 mice per group. Student’s t-test 
reveals no significant difference between control groups or between the experimental 
groups versus their respective controls (P>0.05).  Error bars represent SEM. 
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Figure 7. The collective display of bacterial abundance percentages. Quantitative 
PCR of select bacterial populations using group-specific primers on DNA extracted from 
fecal samples. The abundance of target groups was normalized to the total bacterial 16S 
rRNA gene copies in each sample. Error bars represent SEM. 
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DISCUSSION 
The goal of this study was to characterize the changes that occur among the 
predominate genera of the intestinal microbiota in the presence of Citrobacter rodentium, 
with the long-term goal of applying the results to clinical practice and disease prevention.  
Unexpectedly, the colonization data revealed that C. rodentium DBS100 Strr was able to 
colonize (i.e. maintain stable growth) better in the conventional model than in the 
streptomycin-treated mouse intestine.  The colonization of C. rodentium in the 
conventional mouse intestine was unanticipated in consideration of previous studies, 
which have shown that colonization of E. coli in the conventional model is not displayed 
due to colonization resistance (37).  Recall that the slight inflammatory response induced 
by streptomycin treatment is a contributing factor to colonization success.  The 
colonization advantage observed in the conventional model of this project may be 
explained by the inflammatory response previously observed in the intestines of 
conventional mice infected with C. rodentium strain DBS100 (unpublished data).  It was 
observed that the enteric inflammatory response of the conventional mice was greater 
than that observed in streptomycin-treated mice infected with the same bacteria.  While 
the exact source of inflammation in the conventional mouse is unknown, the response of 
the intestinal microbiota to lipopolysaccharide has been implicated to induce an 
exaggerated inflammatory response in humans (38).  The reason for a colonization 
advantage in the conventional model for C. rodentium is unclear in current research and 
is beyond the scope of this study.   
Concerning the control groups, the qPCR results are consistent with previously 
published data that Bacteroidales populations are elevated with an approximately three-
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fold increase under streptomycin treatment (13).  Curiously, the results indicate that there 
was no significant change in any of the bacterial population abundances for the groups 
colonized with C. rodentium in either model compared to their respective controls.  Both  
Bacteroidales and Clostridia bacteria maintained growth with the colonization of C. 
rodentium even with antibiotic treatment (Figures 1 and 2).  The day 7 results (Figure 4) 
support the previously shown result that Lactobacilli are not significantly altered by 
streptomycin treatment alone.  The seven-fold increase of the Lactobacilli population 
abundance in the colonized, conventional mouse intestine compared to its control has not 
been observed in previous studies.  Unfortunately, the dynamic relationship is not fully 
understood between C. rodentium and Lactobacilli, and would be worth exploring in a 
follow-up experiment.  In the streptomycin-treated mouse intestine, the nearly two-fold 
increase in Lactobacilli population abundance was not considered a significant change, 
which was an expected result since streptomycin-treatment has not had any previous 
indication of affecting the Gram-positive bacterial populations.  However, this nearly 
two-fold increase cannot be ignored as a change to the gut microbial composition for 
future studies since the influence Lactobacilli have on the rest of the microbiota as well 
as the host has not been described.   
The results of this study indicate that the absence of antibiotic treatment in 
addition to the presence of C. rodentium may have a direct impact on other factors 
leading to the promotion of Gram-positive bacterial growth.  The results of the Clostridia 
and Bifidobacteria population abundances (Figures 2 and 5) do not support the 
conclusion that all Gram-positive bacteria benefit (in terms of increased growth) from the 
presence of C. rodentium in the absence (or presence) of continuous antibiotic treatment.  
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To ensure the validity of the unpredicted finding of increased growth of Lactobacilli in 
the conventional and not in the streptomycin-treated model compared to their respective 
controls may warrant a repeated analysis of the genomic DNA with qPCR. 
The colonization differences between EHEC and C. rodentium in the 
conventional model cannot be fully explained by current research, but one contributing 
factor may include the dynamic relationship between C. rodentium and the commensal 
bacterial populations.  Overall, the integrity of these results is called into question in part 
because of the very low abundance percentage values; the collective population 
abundances should comprise the majority of the microbial community.  Notice in each 
figure that the percentages do not sum to 100% (or even come close to this value).  A 
particular example proceeds from the low abundance percentage of Enterobacteriaceae 
(Figure 6).  Especially concerning the amplification of the DNA in the qPCR analysis, 
there are many factors that could affect the results, including the purity of the genomic 
DNA.   
  The microbial composition was defined for only day 7 of the colonization period, 
but the changes in commensal bacteria abundances occurring for the entire duration of 
the colonization experiment must be considered to better characterize the results shown in 
Figure 1.  The genomic DNA quantification of days 1 and 15 will spread light on the 
bacterial population fluctuations and their contribution to the colonization differences 
between both models throughout the 15-day colonization period, and is the goal of future 
work for this study.   
Notice that the colonization data from day 3 was not recorded; this was due to 
misplating, resulting in undetermined CFUs.  In addition, the genomic DNA from the day 
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3 samples extraction is unreliable as the purity of the genomic DNA was compromised 
during the extraction process.  As a result, the day 3 colonization data was not recorded 
and the quantification from day 3 will not be performed in the future.  
The colonization results encourage histopathological scoring of the ceca and small 
intestines of the mice under study.  The histopathology scoring will elucidate whether or 
not the colonization of C. rodentium caused colonic stress, especially that leading to the 
pathogenesis phenotype.  The ceca and colons of the mice used in this study have already 
been isolated in preparation for the continuance of the project along the 
immunohistochemistry branch.   
 Changes occurring in the Bacteroidales, Clostridia, and Enterobacteriaceae 
population levels throughout the colonization period for the colonized, streptomycin-
treated mice when compared to the uncolonized, streptomycin-treated mice are expected 
because of the antibiotic effect on facultative anaerobes.  Based on the day 7 results, 
significant fluctuations for the Lactobacilli population levels in the colonized, 
streptomycin-treated mice when compared to the uncolonized, streptomycin-treated mice 
are not anticipated.  Altered population levels in the colonized, conventional mice when 
compared to the uncolonized, conventional mice are expected for the five bacterial 
genera under study, particularly with the Lactobacilli abundance.  We expect a greater 
significant change in bacterial population levels overall in the streptomycin-treated 
mouse model in relation to the conventional mouse model.  The divergence in 
colonization of C. rodentium is not clearly explained by the present data, which further 
emphasizes the need for the future quantification of all colonization samples of this 
colonization experiment.  The data obtained from the quantification of all of then samples 
THE GUT REACTION  28 
will provide better insight into the interactions between the intestinal microbiota and the 
colonization of C. rodentium in the conventional versus streptomycin-treated mouse 
models.  
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